Form4insider filings, from the source

SEC Form 4 · accession 0001600132-16-000045

Bellerophon Therapeutics, Inc. · BLPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Matthew S. Holt
Director · 10% Owner
Period of report
Apr 28, 2016
Accepted (ET)
Apr 29, 2016 · 3:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockApr 28, 2016A18,232$0.00A18,232D
Common StockF1,F2holding———4,859,885ISee footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses